Capricorn Systems Global Solutions has received a letter of no adverse observation from the Bombay Stock Exchange regarding its proposed scheme of amalgamation with Radical Bio-Organics Limited.

The exchange issued the communication on August 20, 2026, clearing the path for the Hyderabad-based IT services firm to proceed with filing the scheme before the National Company Law Tribunal. The validity of this observation letter is six months from the date of issuance.

Regulatory Requirements

While the stock exchange raised no adverse observations regarding listing requirements, the Securities and Exchange Board of India outlined specific disclosures the company must incorporate into the scheme document. These mandates aim to ensure transparency for public shareholders during the merger process.

Key compliance requirements include:

• Disclosure of all ongoing adjudication, recovery proceedings, or prosecution actions against the company, its promoters, and directors.
• Prominent display of pre- and post-scheme shareholding patterns for promoter and public shareholders on the first page of the shareholder notice.
• Submission of a valuation report and addendum issued by a registered valuer, including justifications for growth rates used in projections.
• Detailed rationale for the merger, swap ratio, business synergies, and cost-benefit analysis.
• Financial statements for all entities involved that are not older than six months from the date of the stock exchange’s no-objection certificate.

Shareholder Impact Disclosures

The regulator emphasized the need for clear communication regarding changes in ownership structure. The company must explain the reasons for any increase in promoter shareholding and its impact on public shareholders’ rights and holding value.

Additionally, the entities must disclose:

• Revenue, net profit, and EBITDA for the last three years for all companies involved in the scheme.
• Value of assets and liabilities being transferred from Radical Bio-Organics to Capricorn Systems.
• No-objection certificates from lending scheduled commercial banks or financial institutions.
• Details of pending legal actions against the entities, promoters, or key managerial personnel and their potential impact on the transferee company.

Next Steps

Capricorn Systems must file the petition before the NCLT within the six-month validity period of the observation letter. The company is required to disclose the no-objection letter on its website within 24 hours of receipt, which it has already done.

The proposed equity shares to be issued under the scheme must be in demat form only. Any changes to the draft scheme beyond those mandated by regulators require specific written consent from SEBI.

Capricorn Systems Global Solutions Limited reported a net profit of ₹93.8 lakh for the quarter ended June 30, 2026 (Q1FY26), marking a 42% decline from the ₹160.4 lakh earned in the preceding quarter. The company’s revenue from operations contracted sharply by 50% quarter-on-quarter to ₹817.69 lakh, reflecting a substantial slowdown in its core agri-products trading business. This performance signals weakening operational momentum as the company navigates lower transaction volumes and persistent losses in its software division.

The Board of Directors approved the unaudited financial results on August 12, 2026, following a review by the Audit Committee. The figures were subjected to a limited review by the statutory auditors, S N M R & Associates, in compliance with Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The Board meeting commenced at 3:00 p.m. IST and concluded at 4:00 p.m. IST.

Segment Performance

The company operates in two distinct segments: Software Development and Processing & Trading in Agri Products. The agri-products segment remains the primary profit driver, though it saw reduced activity compared to the prior quarter.

The Software Development segment reported a loss of ₹4.55 lakh, slightly improving from the ₹8.11 lakh loss recorded in the previous quarter. However, it continues to drag down overall profitability. In contrast, the Agri Products segment generated a profit of ₹17.06 lakh, down from ₹24.66 lakh in the earlier period, aligning with the broader revenue decline.

What the Numbers Show

A critical observation from the filing is the disproportionate reliance on the agri-products segment for profitability. While this segment contributed 97% of total revenue, the software development unit—despite contributing only 3% of revenue—accounted for a significant portion of the operational drag. Furthermore, the company noted an increase in employee benefit expenses due to new labour codes notified by the Ministry of Labour and Employment in November 2025. Although deemed immaterial for exceptional item disclosure in Q4FY26, management is evaluating further impacts on future quarters.

Key Financial Metrics

*Note: Year-over-year comparison shows massive growth from a negligible base of ₹26.51 lakh in Q1FY25.

The company also disclosed that the Scheme of Amalgamation of Radical Bio-Organics Limited with Capricorn Systems, approved on April 11, 2026, is pending regulatory approvals from SEBI, stock exchanges, shareholders, creditors, and the NCLT. The appointed date for the amalgamation is April 1, 2026.